Indications for use of porous hydroxyapatite at time of endosteal implant placement.

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

Placement of coralline porous hydroxyapatite (PHA) at the time of first stage endosteal implant surgery has been shown to be effective in preventing mucosal dehiscence when the buccal cortex is perforated during implant placement. PHA was used to obliterate the space around the occlusal end of endosteal implants placed during tooth extraction. When vital structures would be jeopardized by full implant insertion, PHA can be placed in the area around the protruding implant to prevent mucoperiosteal flap fenestration.

Original languageEnglish (US)
Pages (from-to)322, 324-325
JournalCompendium (Newtown, Pa.)
Volume10
Issue number6
StatePublished - Jun 1 1989
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Indications for use of porous hydroxyapatite at time of endosteal implant placement.'. Together they form a unique fingerprint.

  • Cite this